Middle East and North Africa Active Pharmaceutical Ingredients (APIs) Market Expected to Reach $5.4 Billion by 2027 – An Exclusive Market Research Report by Lucintel

0

“Trends and Forecasts for the Global Active Pharmaceutical Ingredients Market in the Middle East and North Africa”

Middle East and North Africa Active Pharmaceutical Ingredients (API) Market Trends, Opportunities and Forecast to 2027 by Synthesis Type (Synthetic Chemical, Biotech & Biologics, Plant Extracts, Fermentation & Others) ), manufacturer type (captive API and merchant API), therapeutic area (cardiology, oncology, neurology, ophthalmology, orthopedics, pulmonology, food, anti-inflammatory, and others), product form (liquid API and powder API), type of molecule (large molecule and small

Lucintel’s latest market report analyzed that Active Pharmaceutical Ingredient (API) from Middle East and North Africa offers exciting opportunities in the therapeutic areas of cardiology, oncology, neurology, ophthalmology, orthopedics, pulmonology, nutrition and anti-inflammatories. The Middle East and North Africa Active Pharmaceutical Ingredients (API) Market is expected to reach $5.4 billion by 2027 at a CAGR of 7.9%. In this market, synthetic chemistry is the largest segment by type of synthesis, while cardiology is the largest by therapeutic area. Increasing adoption of advanced technologies in API manufacturing, increasing demand for high power APIs, and growing adoption of binders for developing peroxide-sensitive APIs provide an avenue for growth strategy in this market.

Download brochure of this report by clicking on https://www.lucintel.com/middle-eastern-and-north-african-active-pharmaceutical-ingredient-market.aspx On the basis of type of synthesis, the Middle East & North Africa Active Pharmaceutical Ingredients (APIs) market is segmented into Synthetic Chemicals, Biotechnology & Biologics, Plant Extracts, Fermentation, and Others. Synthetic chemicals segment accounted for the largest market share in 2021 and is expected to register the highest CAGR during the forecast period, owing to continuous research and development activities and growing demand for synthetic chemical APIs in therapeutic areas.

Browse in-depth TOC on “Middle East and North Africa Active Pharmaceutical Ingredients (APIs) Market”

71 – Tables

97 – Numbers

158 – Pages

The Middle East and North Africa Active Pharmaceutical Ingredients (API) market is marked by the presence of several large and small players. Pfizer, Teva Pharmaceutical, GSK, Sun Pharmaceutical, Novartis, Aurobindo, Merck & Co., BASF, Julphar and AbbVie are some of the major players offering Active Pharmaceutical Ingredients (APIs) from the Middle East and North Africa.

Request a sample report:

https://www.lucintel.com/middle-eastern-and-north-african-active-pharmaceutical-ingredient-market.aspx

This unique research report will enable you to make business decisions with confidence in this globally competitive market. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click this link [email protected]

About Lucintel

Lucintel, the world’s leading management consulting and market research firm, creates winning strategies for growth. He offers market assessments, competitive analysis, opportunity analysis, growth advice, mergers and acquisitions, and due diligence services to executives and key decision makers in a variety of industries. For more information, visit www.lucintel.com.

Media Contact
Company Name: Lucintel
Contact person: Brandon Fitzgerald
E-mail: Send an email
Call: 303.775.0751
Address:8951 Cypress Waters Blvd, Suite 160
Town: dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/

Share.

Comments are closed.